Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
08/07/2025 14:26
July 8 (Reuters) - An alert on the global oncology market experiencing substantial growth from an FN Media Group commentary tagged to Mustang Bio MBIO.O, Verastem Oncology VSTM.O, AstraZeneca AZN.L, Oncolytics Biotech ONC.TO and Cardiff Oncology CRDF.O was inadvertently published and has been withdrawn. There will be no substitute. STORY_NUMBER:TUA3YKH58 STORY_DATE:08/07/2025 STORY_TIME:[12:50:01] ((bangalore.newsroom@thomsonreuters.com))
Recent news on Cardiff Oncology
See all newsBrief: Cardiff Oncology Receives FDA Orphan Drug Designation For Onvansertib In Chronic Myelomonocytic Leukemia
Corrected: Cardiff Oncology Q2 operating expenses fall on lower R&D costs
Cardiff Oncology Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Cardiff Oncology sinks on direct equity offering